Agricultural biotechnology is advancing quickly – but the regulatory path to market can be anything but straightforward. In this episode, hosts Lauren Petrin and Dr. Alex Stanton explain how the Coordinated Framework splits oversight across USDA, FDA, and EPA, and why gene editing raises new questions that legacy rules weren’t designed to answer. They also examine how the heightened focus on agriculture as a matter of national security is shaping calls for risk-based regulatory modernization –…
By: Wiley Rein LLP
By: Wiley Rein LLP
